Posts In: Indian Pharma Market

PLI scheme. Aurobindo Pharma to make pilot batches in Pen G project by November

The PLI scheme in pharma is likely to translate into production this year as Aurobindo Pharma is expecting to commence manufacturing of pilot batches in...

Continue Reading

Dr Reddy’s Chairman Satish Reddy bags ICT award

Mumbai-based Institute of Chemical Technology (ICT) has awarded the first Dr K Anji Reddy Memorial Fellowship for Affordable Biopharmaceuticals to Satish Reddy, Chairman, Dr Reddy’s...

Continue Reading

Aurobindo Pharma’s Telangana facility gets VAI classification from USFDA

The US Food Drug and Administration (USFDA) has concluded that the inspection classification of Aurobindo Pharma’s API intermiediate facility of Telangana is Voluntary Action Indicated...

Continue Reading

Sun Pharma Acquires Three Anti-Inflammation Brands From Aksigen

Drug major Sun Pharmaceutical Industries on Monday said it has acquired three anti-inflammatory brands from Mumbai-based Aksigen Hospital Care.The company has acquired Disperzyme, Disperzyme-CD and...

Continue Reading

Lupin Launches Aptivate Champion Run for Kids Promoting Well-being and Good Eating Habits

Lupin Life, the Consumer Healthcare division of Lupin, announced the first-ever Aptivate Champion Run for Kids on February 12, 2023, at MMRDA Grounds, Bandra Kurla...

Continue Reading

Bharat Biotech dispatches first shipments of iNCOVACC across India

The Bharat Biotech dispatched the first shipments of the World’s first intranasal Covid19 vaccine INCOVACC to various locations across india.“The first shipments of #iNCOVACC are...

Continue Reading

Aurobindo Pharma receives USFDA nod for osteoarthritis pain relief drug

Hyderabad-based pharmaceutical manufacturing company Aurobindo Pharma said that it has received the nod from the United States Food and Drug Administration (USFDA) for its topical...

Continue Reading

Zydus Life gains as Moraiya facility clears USFDA inspection

Zydus Lifesciences rose 1.70% to Rs 433.35 after the company received nil observations for pre-approval inspection conducted by US Food and Drug Administration (USFDA) at...

Continue Reading

Cipla expands diagnostics portfolio, launches point-of-care testing device

Continuing to expand its presence in the diagnostics segment, pharma major Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions.Another...

Continue Reading